Mats Lindblad is currently a Medical Advisor for Cardiovascular and Renal Metabolism (CVRM) at AstraZeneca, a position held since 2020. Previously, Mats worked at Amgen from 2017 to 2018 as a Regional Medical Liaison, and held various roles including Territory Manager in General Medicine and National Senior Manager for Nephrology in Sweden.
This person is not in the org chart
This person is not in any teams
This person is not in any offices